<DOC>
	<DOCNO>NCT02409082</DOCNO>
	<brief_summary>The investigator explore presence AD factor beta-amyloid tau CSF plasma verify AD diagnosis patient acute hip fracture . Clinical dementia test perform prior operation . Blood sample CSF sample collect surgery blood sample collect postoperatively interval . Mortality assess 30 day , 3 month 1 year . Morbidity assess , 3 month &gt; 1 year . Neuromarkers specifically address inflammatory component analyze correlated outcome together AD marker , .</brief_summary>
	<brief_title>Alzheimers Disease Neuromarkers Patients With Acute Hip Fractures</brief_title>
	<detailed_description>The hypothesis explore investigation patient pre-AD AD bad prognosis follow acute hip fracture . This demonstrate retrospective study . In study admit patient hip fracture plan tro receive spinal anesthesia . Our golden standard anesthesia patient cohort . Preoperatively Clinical Dementia Score assess study inclosure . At performance spinal dosage standardize . Prior give 5 ml CSF collect blood collect . Blood collected interval day 3 postoperatively . We plan analyze beta-amyloid tau CSF plasma verify AD diagnosis patient acute hip fracture . Mortality assess 30 day , 3 month 1 year . Morbidity assess , 3 month &gt; 1 year . Neuromarkers specifically address inflammatory component analyze correlated outcome together AD marker , .</detailed_description>
	<mesh_term>Fractures , Bone</mesh_term>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Hip Fractures</mesh_term>
	<criteria>Hip fracture plan spinal anesthesia Not receive spinal anesthesia i.e . CSF available</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>